SLS - SELLAS Life Sciences Group Inc. PEG multiplikatori
Galinpepimut-S vaksinasi tasdiqlangandan keyin kutilayotgan narx belgilash imkoniyati SELLAS Life Sciences (SLS) uchun kuchli o'sish potentsialini yaratadi. Peg_co koeffitsiyenti joriy dinamikani namoyish etadi, bunda 0.00 belgisi aktivning hozirgi holatini aks ettiradi. Leykozga qarshi kurash orqali diversifikatsiya qilish risklarni minimallashtiradi, innovatsion, ammo spekulyativ ishlab chiquvchi maqomi esa klinik sinovlar natijalari kutilayotgan bir paytda yuqori narx tebranishlarini saqlab qoladi.
SELLAS Life Sciences (SLS) kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti SELLAS Life Sciences|SLS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati sellaslifesciences.com|SLS - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati SELLAS Life Sciences Group Inc.|SLS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi SELLAS Life Sciences|Tezkor likvidlik koeffitsiyenti sellaslifesciences.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
SLS - Kompaniyaning sof foydasi|Kompaniya foydasi prognozi SELLAS Life Sciences|SLS - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori sellaslifesciences.com|SLS - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati SELLAS Life Sciences Group Inc.|SLS - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda SELLAS Life Sciences|SLS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi sellaslifesciences.com|SLS - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi SELLAS Life Sciences
Kompaniyaning fundamental tahlili:SELLAS Life Sciences Group, Inc. SLS
SELLAS Life Sciences biotex ekotizimi yuqori bozor potensialiga ega, biroq mahsulotlarning to'liq tijoratlashtirilishi FDA tasdiqlari kutilayotgani sababli cheklangan. Ushbu ko'rsatkich bozor qiymatini foyda o'sish sur'atlari bilan solishtiradi, bunda birdan past qiymatlar aktivning qadrini past baholanganini anglatadi va PEG ko'rsatkichi tahlili orqali istiqbolli kirish nuqtalarini aniqlash imkonini beradi.
SELLAS Life Sciences raqobatchilari
Narx-foyda va o‘sish multiplikatori BeiGene Ltd. ONC|Halozyme Inc. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Revolution Medicines Corp RVMD|AAPG - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CGON (cgoncology.com)|URGN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Bicara Therapeutics Inc (BCAX)|Narxning foydaga va o‘sish sur’atiga nisbati Personalis Corp|Erasca Oncology (ERAS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|PEG multiplikatori DCTH|YMAB - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Aura Biosciences AURA|Candel Therapeutics Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|ARAY - Narxning foydaga va o‘sish sur’atiga nisbati|ACTU: Narxning foydaga va o‘sish sur’atiga nisbati|CTOR: PEG multiplikatori|TuHURA Biosciences (HURA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Protara Therapeutics, Inc.|Fate Therapeutics Inc (FATE) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori WHWK (Aadi Bioscience Inc)|TCRX (tscan.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Champions Oncology, Inc. CSBR|XBiotech Inc - Narxning foydaga va o‘sish sur’atiga nisbati|CEL-SCI Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati OS Therapies Inc. OSTX|RADX: PEG multiplikatori|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati ARTV (Artiva Biotherapeutics)|ANL (Adlai Nortye Ltd) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda verupharma.com VERU|Narx-foyda va o‘sish multiplikatori TPST (Tempest Therapeutics, Inc.)|XLO (xiliotx.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Renovaro RENB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Mural Oncology PLC (MURA)|Kairos Pharma Inc - PEG multiplikatori|OnKure Therapeutics Inc (OKUR) - Narx-foyda va o‘sish multiplikatori|GDTC: PEG multiplikatori|CRIS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|APLM (Apollomics Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tharimmune Corporation THAR|Narxning foydaga va o‘sish sur’atiga nisbati Advanced Biomed Inc (ADVB)|genprex.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Narx-foyda va o‘sish multiplikatori|Xenetic Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Salarius Pharma|Purple Biotech (PPBT) - Narxning foydaga va o‘sish sur’atiga nisbati|AONC - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati BeiGene|Checkpoint Therapeutics Inc. (CKPT) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Elevation Oncology, Inc. (ELEV)|Narxning foydaga va o‘sish sur’atiga nisbati ICAD (icadmed.com)|Narxning foydaga va o‘sish sur’atiga nisbati Ikena Oncology IKNA|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati notablelabs.com (NTBL)|Viracta - PEG multiplikatori|MorphoSys Inc (MOR) - Narx-foyda va o‘sish multiplikatori|NAYA: PEG multiplikatori|Ascentage (AAPGV) - PEG multiplikatori
